关注
Mark Langowski
Mark Langowski
未知所在单位机构
在 uw.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Modeling-enabled characterization of novel NLRX1 ligands
P Lu, R Hontecillas, V Abedi, S Kale, A Leber, C Heltzel, M Langowski, ...
PLoS One 10 (12), e0145420, 2015
352015
Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform
MD Langowski, FA Khan, AA Bitzer, CJ Genito, AJ Schrader, ML Martin, ...
Proceedings of the National Academy of Sciences 117 (6), 3114-3122, 2020
332020
Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum
MD Langowski, FA Khan, S Savransky, DR Brown, A Balasubramaniyam, ...
npj Vaccines 7 (1), 13, 2022
162022
Tobamovirus-based virus-like particles and vaccines
S Dutta, A Batchelor, F Khan, M Langowski
US Patent 11,285,204, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–4